AngioDynamics (ANGO) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on AngioDynamics (ANGO) is Neutral.

The composite score behind that read is -0.08, weighing +0.23 of bullish evidence against -0.25 bearish.

AngioDynamics last closed at $11.52, +2.58% on the session.

Against the IVW growth benchmark the position is +1.78% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

4 graded predictions for ANGO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks AngioDynamics in the 27th percentile on return on equity, where 100 is best.

AngioDynamics is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $472.27M.

StockMap tracks AngioDynamics as the 74th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite AngioDynamics ranks 82nd of 140 in the group, against a group median of -0.03.